To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    European Hospital Beds Market size was valued at USD 1.65 Billion in 2024 and is poised to grow from USD 1.73 Billion in 2025 to USD 2.47 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026–2033). 

    The European hospital beds market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Hill Rom Holding inc. (Baxter) ', 'Stryker Corporation ', 'Arjo Medical Devices ', 'Invacare Corporation ', 'Malvestio Spa ', 'Savion Industries ', 'STIEGELMEYER GMBH & CO.KG ', 'Lojer ', 'Huntleigh ', 'Linet ', 'Proma Reha ', 'Merivaara '

    In accordance with the Organization for Economic Cooperation and Development (OECD) Labour Force statistics, four European countries ranked in the top five among G7 countries, with Germany ranking second, accounting for 21.4% of the population aged 65 and up. As a result, the aging population is increasing the prevalence of chronic diseases. According to the European Commission, the share of noncommunicable diseases (NCDs) in the overall disease burden in Disability Adjusted Life Year (DALYs) in Europe is anticipated to increase from 78% in 2008 to 84% in 2030. These factors will boost the market growth during the forecast period.

    Increasing technological advancements is improving healthcare facilities due to increasing hospitalization cases on account of critical diseases or injuries, frequent accidental rates. The available number of key businesses is supporting the market to increase the revenue share.

    An assessment of the quantity of hospital beds in direct proportion to population demonstrates that there were 538 per 100 000 inhabitants on average across the EU-27 in 2018.

    Feedback From Our Clients

    European Hospital Beds Market

    Report ID: SQMIR35B2196

    $3,500
    BUY NOW